{"id":"NCT00943579","sponsor":"The Children's Health Council","briefTitle":"Open-Label Extension Study of Kuvan for Autism","officialTitle":"Kuvan® (Sapropterin) as a Treatment for Autistic Disorder: An Open Label Extension Protocol","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2009-08","primaryCompletion":"2011-12","completion":"2012-03","firstPosted":"2009-07-22","resultsPosted":"2013-07-04","lastUpdate":"2018-05-02"},"enrollment":41,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Autistic Disorder"],"interventions":[{"type":"DRUG","name":"Kuvan®","otherNames":["sapropterin","tetrahydrobiopterin"]}],"arms":[{"label":"Kuvan®","type":"EXPERIMENTAL"}],"summary":"This is an open-label extension study available only to subjects who completed an earlier double-blind, placebo-controlled study of sapropterin in children with autism.","primaryOutcome":{"measure":"Clinical Global Impressions Scale","timeFrame":"16 weeks","effectByArm":[{"arm":"Kuvan Following Placebo","deltaMin":3,"sd":null},{"arm":"Kuvan Following Active Treatment","deltaMin":3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":">.05"}]},"eligibility":{"minAge":"3 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":1},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":21},"commonTop":["Difficulty Sleeping","Changes in bowel movements","Repetitive Behaviors","Irritability","Hyperactivity"]}}